The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Open accessAbstract
Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although TP53 mutations are oncogenic in GBM, other genes, such as PTEN must also be mutated to drive GBM progression [28].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citationErratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citationClarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Cited by
Sorted by citations
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationCancer stem cells in glioblastoma
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L., & Rich, J. N. (2015) · Genes & Development · doi:10.1101/gad.261982.115 · Cited by 1,520
Unravelling mechanisms of p53-mediated tumour suppression
Bieging-Rolett, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3711 · Cited by 1,459
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Sanson, M., Marie, Y., Paris, S., Idbaïh, A., Laffaire, J., Ducray, F., Hallani, S. E., Boisselier, B., Mokhtari, K., Hoang‐Xuan, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9832 · Cited by 1,049
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 959
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationCasares, D., Escribá, P. V., & Rosselló, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092167 · Cited by 863
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3037 · Cited by 793
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2818 · Cited by 783
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Wu, C.-J., Sadanandam, A., Hu, B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.003 · Cited by 716
Self-citationIntegrin Alpha 6 Regulates Glioblastoma Stem Cells
Lathia, J. D., Gallagher, J., Heddleston, J. M., Wang, J., Eyler, C. E., MacSwords, J., Wu, Q., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.02.018 · Cited by 655
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Emerging insights into the molecular and cellular basis of glioblastomaPreprint
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 573
Self-citationA Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Overcoming therapeutic resistance in glioblastoma: the way forward
Osuka, S., & Meir, E. G. V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89587 · Cited by 526
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C., Chu, G. C., Xiao, Y., Ho, D. C., Zhang, J., Perry, S. R., Labrot, E., Wu, X., Lis, R. T., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 517
Self-citationEZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Suvà, M.-L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J., Baumer, K., Bitoux, M. L., Marino, D., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1622 · Cited by 466
FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell Homeostasis
Paik, J.-H., Ding, Z., Narurkar, R., Ramkissoon, S., Muller, F., Kamoun, W. S., Chae, S.-S., Zheng, H., Ying, H., Mahoney, J., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.013 · Cited by 459
Self-citationRecent advances in the molecular understanding of glioblastoma
Bleeker, F. E., Molenaar, R. J., & Leenstra, S. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0793-0 · Cited by 468
The p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Lin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 462
Genetically engineered cerebral organoids model brain tumor formation
Bian, S., Repic, M., Guo, Z., Kavirayani, A. M., Burkard, T. R., Bagley, J. A., Krauditsch, C., & Knoblich, J. A. (2018) · Nature Methods · doi:10.1038/s41592-018-0070-7 · Cited by 427
Sansom, S. N., Griffiths, D. S., Faedo, A., Kleinjan, D., Ruan, Y., Smith, J. C., van Heyningen, V., Rubenstein, J. L. R., & Livesey, F. J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000511 · Cited by 401
Chen, J., Huang, Z., Seok, H., Ding, J., Kataoka, M., Zhang, Z., Hu, X., Wang, G., Lin, Z., Wang, S., et al. (2013) · Circulation Research · doi:10.1161/circresaha.112.300658 · Cited by 403
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Ozawa, T., Riester, M., Cheng, Y.-K., Huse, J. T., Squatrito, M., Helmy, K. Y., Charles, N. A., Michor, F., & Holland, E. C. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.005 · Cited by 393
Emerging treatment strategies for glioblastoma multiforme
Carlsson, S. K., Brothers, S. P., & Wahlestedt, C. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302627 · Cited by 380
Lake-Front Property: A Unique Germinal Niche by the Lateral Ventricles of the Adult Brain
Ihrie, R. A., & Álvarez-Buylla, A. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.004 · Cited by 356
Passenger deletions generate therapeutic vulnerabilities in cancer
Muller, F. L., Colla, S., Aquilanti, E., Manzo, V. E., Genovese, G., Lee, J., Eisenson, D., Narurkar, R., Deng, P., Nezi, L., et al. (2012) · Nature · doi:10.1038/nature11331 · Cited by 339
Self-citationOverexpression of the long non‐coding RNA MEG3 impairs in vitro glioma cell proliferation
Wang, P., Ren, Z., & Sun, P. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24055 · Cited by 337
Adult neural stem cells in the mammalian central nervous system
Ma, D. K., Bonaguidi, M. A., Ming, G., & Song, H. (2009) · Cell Research · doi:10.1038/cr.2009.56 · Cited by 338
Inactivation of p53 and Pten promotes invasive bladder cancerPreprint
Puzio‐Kuter, A. M., Castillo-Martín, M., Kinkade, C. W., Wang, X., Shen, T. H., Matos, T., Shen, M. M., Cordon‐Cardo, C., & Abate-Shen, C. T. (2009) · Genes & Development · doi:10.1101/gad.1772909 · Cited by 334
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Bai, H., Harmancı, A. S., Erson-Omay, Z., Li, J., Coşkun, S., Simon, M., Krischek, B., Özduman, K., Omay, S. B., Sorensen, E. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3457 · Cited by 328
BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J., & Bernier, G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0968-09.2009 · Cited by 333
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Taylor, O. G., Brzozowski, J. S., & Skelding, K. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00963 · Cited by 329
Neural stem cell systems: physiological players or in vitro entities?
Conti, L., & Cattaneo, E. F. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2761 · Cited by 330
An Animal Model of MYC-Driven Medulloblastoma
Pei, Y., Moore, C. E., Wang, J., Tewari, A. K., Eroshkin, A. M., Cho, Y., Witt, H., Korshunov, A., Read, T., Sun, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.021 · Cited by 316
Role of Phospholipids in Endocytosis, Phagocytosis, and Macropinocytosis
Bohdanowicz, M., & Grinstein, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2012 · Cited by 326
Chow, L. M. L., Endersby, R., Zhu, X., Rankin, S. L., Qu, C., Zhang, J., Broniscer, A., Ellison, D. W., & Baker, S. J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.039 · Cited by 303
Wang, L., Xiong, H., Wu, F., Zhang, Y., Wang, J., Zhao, L., Guo, X., Chang, L.-J., Zhang, Y., You, M. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.053 · Cited by 299
Self-citationEpigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Hu, B., Wang, Q., Wang, Y., Hua, S., Sauvé, C.-E. G., Ong, D. S. T., Lan, Z. D., Chang, Q., Ho, Y. W., Monasterio, M. M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.039 · Cited by 277
Self-citationLottaz, C., Beier, D., Meyer, K., Kumar, P., Hermann, A., Schwarz, J., Junker, M., Oefner, P. J., Bogdahn, U., Wischhusen, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1707 · Cited by 268
PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas
Zheng, H., Ying, H., Wiedemeyer, R., Yan, H., Quayle, S. N., Ivanova, E. V., Paik, J. H., Zhang, H., Xiao, Y., Perry, S. R., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.020 · Cited by 273
Self-citationThe Pathobiology of Glioma Tumors
Gladson, C. L., Prayson, R. A., & Liu, W. M. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102109 · Cited by 268
Wang, Y., Yang, J., Zheng, H., Tomasek, G. J., Zhang, P., McKeever, P. E., Lee, E. Y.-H. P., & Zhu, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.001 · Cited by 256
Self-citationPI(3)King Apart PTEN's Role in Cancer
Zhang, S., & Yu, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2990 · Cited by 254
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Wakimoto, H., Mohapatra, G., Kanai, R., Curry, W. T., Yip, S. S. F., Nitta, M., Patel, A. P., Barnard, Z. R., Stemmer-Rachamimov, A. O., Louis, D. N., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor195 · Cited by 245
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Huang, Z., Cheng, L., Guryanova, O. A., Wu, Q., & Bao, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0078-y · Cited by 248
Deconstructing networks of p53-mediated tumor suppression in vivo
Kaiser, A. M., & Attardi, L. D. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.171 · Cited by 232
Ying, H., Elpek, K. G., Vinjamoori, A., Zimmerman, S. M., Chu, G. C., Yan, H., Fletcher-Sananikone, E., Zhang, H., Liu, Y., Wang, W., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0031 · Cited by 223
Self-citationThe cellular origin for malignant glioma and prospects for clinical advancements
Zong, H., Verhaak, R. G. W., & Canoll, P. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.30 · Cited by 234
Ding, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220
Self-citationSunayama, J., Matsuda, K.-I., Sato, A., Tachibana, K., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., Kayama, T., Tomiyama, A., et al. (2010) · Stem Cells · doi:10.1002/stem.521 · Cited by 218
Binda, E., Visioli, A., Giani, F., Lamorte, G., Copetti, M., Pitter, K. L., Huse, J. T., Cajola, L., Zanetti, N., DiMeco, F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.005 · Cited by 225
Wang, W., Wu, S.-P., Liu, J., Shi, Y., Huang, X. P., Zhang, Q.-B., & Yao, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1408 · Cited by 217
Jacques, T. S., Swales, A., Brzozowski, M. J., Henriquez, N. V., Linehan, J. M., Mirzadeh, Z., O' Malley, C., Naumann, H., Alvarez‐Buylla, A., & Brandner, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.327 · Cited by 214
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Biddlestone-Thorpe, L., Sajjad, M., Rosenberg, E., Beckta, J. M., Valerie, N. C. K., Tokarz, M. E., Adams, B. R., Wagner, A. F., Khalil, A. A., Gilfor, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3408 · Cited by 219
Acute promyelocytic leukemia, arsenic, and PML bodies
de Thé, H., Bras, M. L., & Lallemand-Breitenbach, V. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201112044 · Cited by 212
Biology of Angiogenesis and Invasion in Glioma
Tate, M. C., & Aghi, M. K. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.001 · Cited by 212
Mollaoglu, G., Jones, A. D., Wait, S. J., Mukhopadhyay, A., Jeong, S., Arya, R. S., Camolotto, S. A., Mosbruger, T. L., Stubben, C., Conley, C. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.020 · Cited by 215
Calvert, A. E., Chalastanis, A., Wu, Y., Hurley, L., Kouri, F. M., Bi, Y., Kachman, M. T., May, J., Bartom, E. T., Hua, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.014 · Cited by 212
Self-citationA Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
Read, R. D., Cavenee, W. K., Furnari, F. B., & Thomas, J. B. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000374 · Cited by 212
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
Wang, X., Yang, K., Xie, Q., Wu, Q., Mack, S. C., Shi, Y., Kim, L. J. Y., Prager, B. C., Flavahan, W. A., Liu, X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4537 · Cited by 206
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Sarkar, S., Döring, A., Zemp, F. J., Silva, C., Lun, X. Q., Wang, X., Kelly, J. J., Hader, W. J., Hamilton, M. G., Mercier, P., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3597 · Cited by 207
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
Yin, J., Zeng, A., Zhang, Z., Shi, Z., Yan, W., & You, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.016 · Cited by 203
Brain tumor stem cells: Molecular characteristics and their impact on therapy
Schonberg, D. L., Lubelski, D., Miller, T. E., & Rich, J. N. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.004 · Cited by 204
Potential therapeutic implications of cancer stem cells in glioblastoma
Cheng, L., Bao, S., & Rich, J. N. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.035 · Cited by 200
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 196
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Luongo, F., Colonna, F., Calapà, F., Vitale, S., Fiori, M. E., & Maria, R. D. (2019) · Cancers · doi:10.3390/cancers11081076 · Cited by 200
Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
Woo, H. G., Lee, J., Yoon, J., Kim, C. Y., Lee, H., Jang, J. J., Yi, N., Suh, K., Lee, K. U., Park, E. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2823 · Cited by 191
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2675 · Cited by 195
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
Papagiannakopoulos, T., Friedmann-Morvinski, D., Neveu, P., Dugas, J. C., Gill, R. M., Huillard, E., Liu, C., Zong, H., Rowitch, D. H., Barres, B. A., et al. (2012) · Oncogene · doi:10.1038/onc.2011.380 · Cited by 157
Yang, P., Wang, Y., Peng, X., You, G., Zhang, W., Yan, W., Bao, Z., Wang, Y., Qiu, X., & Jiang, T. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1103-9 · Cited by 183
Self-citationPDGF and PDGF receptors in glioma
Nazarenko, I., Hede, S., He, X., Hedrén, A., Thompson, J., Lindström, M. S., & Nistér, M. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.665097 · Cited by 191
Glioblastoma cancer stem cell biology: Potential theranostic targets
Sharifzad, F., Ghavami, S., Verdi, J., Mardpour, S., Sisakht, M. M., Azizi, Z., Taghikhani, A., Łoś, M., Fakharian, E., Ebrahimi, M., et al. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.003 · Cited by 186
Ernst, A., Hofmann, S., Ahmadi, R., Becker, N., Korshunov, A., Engel, F., Hartmann, C. J., Felsberg, J., Sabel, M., Peterziel, H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0695 · Cited by 171
Bártková, J., Hamerlik, P., Stockhausen, M.-T., Ehrmann, J., Hlobílková, A., Laursen, H. B., Kalita, O., Kolář, Z., Poulsen, H. S., Broholm, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.249 · Cited by 174
MicroRNA-146a Inhibits Glioma Development by Targeting Notch1
Mei, J., Bachoo, R. M., & Zhang, C. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05821-11 · Cited by 174
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L., Li, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10068 · Cited by 172
Zhuang, W., Li, B.-Z., Long, L., Chen, L., Huang, Q., & Liang, Z. (2011) · International Journal of Cancer · doi:10.1002/ijc.25975 · Cited by 170
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint
Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 175
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163
Fidoamore, A., Cristiano, L., Antonosante, A., d’Angelo, M., Giacomo, E. D., Astarita, C., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2016) · Stem Cells International · doi:10.1155/2016/6809105 · Cited by 175
Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting
Persano, L., Rampazzo, E., Basso, G., & Viola, G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.001 · Cited by 177
Bian, S., Hong, J., Li, Q., Schebelle, L., Pollock, A., Knauss, J. L., Garg, V., & Sun, T. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.037 · Cited by 161
Myc-Driven glycolysis is a therapeutic target in glioblastoma
Tateishi, K., Iafrate, A. J., Ho, Q., Curry, W. T., Batchelor, T. T., Flaherty, K. T., Onozato, M. L., Lelic, N., Sundaram, S., Cahill, D. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2274 · Cited by 160
The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon
Tedeschi, A., & Giovanni, S. D. (2009) · EMBO Reports · doi:10.1038/embor.2009.89 · Cited by 163
Kim, S. S., Rait, A. S., Kim, E. H., Pirollo, K. F., Nishida, M., Farkas, N., Dagata, J. A., & Chang, E. H. (2014) · ACS Nano · doi:10.1021/nn5014484 · Cited by 158
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 161
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Dumas, A. A., Pomella, N., Rosser, G., Guglielmi, L., Vinel, C., Millner, T. O., Rees, J. H., Aley, N., Sheer, D., Wei, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103790 · Cited by 159
Asymmetric cell division of stem and progenitor cells during homeostasis and cancer
Gómez‐López, S., Lerner, R. G., & Petritsch, C. K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1386-1 · Cited by 159
Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchyPreprint
Yan, K., Wu, Q., Yan, D. H., Lee, C. H., Rahim, N., Tritschler, I., DeVecchio, J., Kalady, M. F., Hjelmeland, A. B., & Rich, J. N. (2014) · Genes & Development · doi:10.1101/gad.235515.113 · Cited by 158
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 160
Talasila, K. M., Soentgerath, A., Euskirchen, P., Røsland, G. V., Wang, J., Huszthy, P. C., Prestegarden, L., Skaftnesmo, K. O., Sakariassen, P. Ø., Eskilsson, E., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1101-1 · Cited by 153
What is bad in cancer is good in the embryo: Importance of EMT in neural crest development
Kerosuo, L., & Bronner-Fraser, M. E. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.03.010 · Cited by 153
AKT1 Activation Promotes Development of Melanoma Metastases
Cho, J. H., Robinson, J. P., Arave, R. A., Burnett, W. J., Kircher, D. A., Chen, G., Davies, M. A., Grossmann, A. H., VanBrocklin, M. W., McMahon, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.057 · Cited by 146
Li, J., Zhu, S., Kozono, D., Ng, K., Futalan, D., Shen, Y. H., Akers, J. C., Steed, T., Kushwaha, D. S., Schlabach, M. R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1801 · Cited by 147
Metadata
- Authors
- Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Stanford University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7216
- Pages
- 1129-1133
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4051433
- OpenAlex
- W2109610561
- Cited by
- 767
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
- MeSH terms
- Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
